PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION

Lobbying for PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 14, 2026

Expenses

$50,000.00

What this organization spent lobbying with its own staff. Reported using C: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

New Jersey

Official filing document

Lobbyists on this filing 1

GIL ROTH

Previously held: not applicable

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 1

Bureau of Industry and Security (BIS)

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 4

Manufacturing

Discussed issues related to biopharma supply chain tariff implementation, onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, and workforce development

Pharmacy

Discussed issues related to biopharma supply chain tariff implementation, onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, and workforce development

Tariff (miscellaneous tariff bills)

Discussed issues related to biopharma supply chain tariff implementation, onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, and workforce development

Health Issues

Discussed issues related to biopharma supply chain tariff implementation, onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, and workforce development

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.